Sunday
2:00 pm - 9:00 pm
Arrival and Check-in
6:00 pm - 7:00 pm
Dinner
7:30 pm - 7:40 pm
Introductory Comments by GRC Staff / Welcome and Introduction from the Chairs
7:40 pm - 9:30 pm
Keynote Session: Evolving Functionality of the Fibrinolytic System Through the Decades
7:40 pm - 7:45 pm
Opening Remarks
7:45 pm - 8:05 pm
Introduction by Discussion Leader
8:05 pm - 8:40 pm
"Plasminogen Receptors: The More We Learn, The More We Question"
8:40 pm - 8:50 pm
Discussion
8:50 pm - 9:20 pm
"Plasminogen Activation and Extracellular Proteolysis: From Bedside to Bench and Back Again"
9:20 pm - 9:30 pm
Discussion
Monday
7:30 am - 8:30 am
Breakfast
8:30 am - 9:00 am
Group Photo
9:00 am - 12:30 pm
Thrombotic Disorders: Basic Research and Its Impact in Clinical Management
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:25 am
"Meeting the tPA Challenge: Use of Viscoelastic Tests to Guide Trauma Care"
9:25 am - 9:35 am
Discussion
9:35 am - 9:55 am
"The Story of Tranexamic Acid in Acute Severe Bleeding"
9:55 am - 10:05 am
Discussion
10:05 am - 10:25 am
"A Novel Antiplasmin Inhibitor: From Preclinical Study to First in Human Evaluation"
10:25 am - 10:35 am
Discussion
10:35 am - 11:00 am
Coffee Break
11:00 am - 11:20 am
"Clinical Manifestation of Plasminogen Deficiency"
11:20 am - 11:30 am
Discussion
11:30 am - 11:50 am
"Three Distinct Clot Lysis Assays to Detect Activities of Alpha2 Antiplasmin, PAI-1 and TM/TAFI: Their Applications to Assess TXA Necessity, PAI-1 Deficiency and Soluble TM Function in Plasma"
11:50 am - 12:00 pm
Discussion
12:00 pm - 12:10 pm
"Host Fibrinolytic Deficiencies Enhance Pathogen Colonization in the Catheterized Bladder Environment and Promote Systemic Dissemination"
12:10 pm - 12:15 pm
Discussion
12:15 pm - 12:25 pm
"PAI-1 Requires Sortilin-Related Receptor 1 to Exert Its Profibrotic Effects"
12:25 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
3:00 pm - 4:00 pm
The GRC Power Hour™
The GRC Power Hour™ is designed to address diversity and inclusion in the scientific workplace by providing a safe environment for informal and meaningful conversations amongst colleagues of all career stages. The program supports the professional growth of all members of our communities, including ethnicity, race and/or gender identity by providing an open forum for discussion and mentoring.
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
Proteases in Metabolic Diseases and Aging
7:30 pm - 7:35 pm
Introduction by Discussion Leader
7:35 pm - 7:55 pm
"Evolutionary Advantage of Heterozygous PAI-1 Deficiency in Humans"
7:55 pm - 8:05 pm
Discussion
8:05 pm - 8:25 pm
"Senescent Cells: Conversations with Their Neighbors"
8:25 pm - 8:35 pm
Discussion
8:35 pm - 8:55 pm
"Plasminogen and uPA in the Pathogenesis of Obesity and Metabolic Syndrome"
8:55 pm - 9:00 pm
Discussion
9:00 pm - 9:10 pm
"MT1-MMP: A New Therapautic Target of Obesity and Diabetes"
9:10 pm - 9:15 pm
Discussion
9:15 pm - 9:25 pm
"The Reciprocal Relationship Between Coagulation Factor VIII and apoB-Lipoprotein"
9:25 pm - 9:30 pm
Discussion
Tuesday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Inflammatory Diseases and Cancer: MMP, tPA and Plasminogen
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:25 am
"Targeting Pathophysiological Proteolytic Networks"
9:25 am - 9:35 am
Discussion
9:35 am - 9:55 am
"Metalloprotease Inhibitors as Regulators of Tissue Stem Cell Fate"
9:55 am - 10:05 am
Discussion
10:05 am - 10:25 am
"Structure-Function Studies of a Novel Bacterial MMP Inhibitor and of Celiacase: A Promising Therapeutic Agent for Celiac Disease"
10:25 am - 10:35 am
Discussion
10:35 am - 11:00 am
Coffee Break
11:00 am - 11:20 am
"Multiomic Profiling of Fibrin-Induced Microglia Functions in Neurodegeneration"
11:20 am - 11:30 am
Discussion
11:30 am - 11:50 am
"Plasminogen Activator Receptors as Regulators of Cell Physiology"
11:50 am - 12:00 pm
Discussion
12:00 pm - 12:20 pm
"Membrane-Anchored Serine Proteases in Epithelial Homeostasis and Disease"
12:20 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
Proteases in Infection and Immunity
7:30 pm - 7:35 pm
Introduction by Discussion Leader
7:35 pm - 7:55 pm
"Neutrophil Activation in Thromboinflammatory Syndromes"
7:55 pm - 8:05 pm
Discussion
8:05 pm - 8:25 pm
"Group A Streptococcal Interactions with Blood System Components Revealed Through Live Imaging"
8:25 pm - 8:35 pm
Discussion
8:35 pm - 8:55 pm
"Recent Advances Identifying Structural Requirements for Accelerated Plasminogen Activation by Group A Streptococcus Plasminogen-Binding Proteins"
8:55 pm - 9:00 pm
Discussion
9:00 pm - 9:10 pm
"Targeting of Factor XII by CpaA, A Secreted Acinetobacter Glycoprotease Impairs Contact Activation and Neutrophil Functions"
9:10 pm - 9:15 pm
Discussion
9:15 pm - 9:25 pm
"Targeting the uPAR System in Pancreatic Cancer: A Novel Antibody-Drug-Conjugate Approach Eliciting Tumor Regression and Immune Activation"
9:25 pm - 9:30 pm
Discussion
Wednesday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Cerebrovascular Diseases: Imaging, Function and Mechanism
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:25 am
"Fibrin in Neurological Diseases: Mechanisms, Imaging, Therapeutics"
9:25 am - 9:35 am
Discussion
9:35 am - 9:55 am
"tPA’s Role in Neurovascular Function, Dysfunction and Alzheimer Pathology"
9:55 am - 10:05 am
Discussion
10:05 am - 10:25 am
"Role of tPA in Metabolism: Implications in Stroke Therapy"
10:25 am - 10:35 am
Discussion
10:35 am - 11:00 am
Coffee Break
11:00 am - 11:20 am
"Latest Insights into tPA-Mediated NMDA Receptor Signaling via a Specific Knock-In Model"
11:20 am - 11:30 am
Discussion
11:30 am - 11:50 am
"Targeting the Plasma Contact System to Ameliorate Vascular Dysfunction and Inflammation in Alzheimer’s Disease"
11:50 am - 12:00 pm
Discussion
12:00 pm - 12:10 pm
"Glunomab: AN mAb Preventing Blood-Brain Barrier Disruption Caused by Endogenous tPA and Thrombolytic Drugs Following Ischemic Stroke"
12:10 pm - 12:15 pm
Discussion
12:15 pm - 12:25 pm
"Fibrin Promotes Oxidative Stress and Neuronal Loss in Traumatic Brain Injury via Innate Immune Activation"
12:25 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
Proteases in Musculoskeletal Diseases
7:30 pm - 7:35 pm
Introduction by Discussion Leader
7:35 pm - 7:55 pm
"Integrated Forward and Reverse Degradomics of Human Diseases"
7:55 pm - 8:05 pm
Discussion
8:05 pm - 8:25 pm
"Metalloproteases ADAMTS13 and ADAMTS7: Substrate Processing and Regulation"
8:25 pm - 8:35 pm
Discussion
8:35 pm - 8:55 pm
"An Update of Plasminogen's Role in Orthopedic Injury"
8:55 pm - 9:00 pm
Discussion
9:00 pm - 9:10 pm
"Unveiling a Novel Cleavage Site: Plasmin-Resistant tPA Isoforms and Their Functional Roles"
9:10 pm - 9:15 pm
Discussion
9:15 pm - 9:25 pm
"Critical Role of Fibrinolysis in Hematopoietic Recovery After Myelosuppression"
9:25 pm - 9:30 pm
Discussion
Thursday
7:30 am - 8:30 am
Breakfast
8:30 am - 9:00 am
Business Meeting
Nominations for the Next Vice Chair(s); Complete the GRC Evaluation Forms; Election of the Next Vice Chair(s)
9:00 am - 12:30 pm
Emerging Technologies to Dissect Protease Function
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:25 am
"Application of Small Molecule and Biological Probes in the Discovery and Quantitation of IBD-Associated Proteases"
9:25 am - 9:35 am
Discussion
9:35 am - 9:55 am
"Proteolysis and Blood Brain Barrier Changes in Alzheimer’s Disease"
9:55 am - 10:05 am
Discussion
10:05 am - 10:25 am
"Fibrinolysis and Thrombolysis in Thrombus Resolution"
10:25 am - 10:35 am
Discussion
10:35 am - 11:00 am
Coffee Break
11:00 am - 11:20 am
"Novel Blood-Compatible Macromolecular Sensors for Proteases"
11:20 am - 11:30 am
Discussion
11:30 am - 11:50 am
"Bioinspired Nanotherapeutics for Targeted Fibrinolysis"
11:50 am - 12:00 pm
Discussion
12:00 pm - 12:20 pm
"Deep Mutational Scanning to Map PAI-1 Functional Specificity and Evolution"
12:20 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
Proteases in Cutting-Edge Therapeutics
7:30 pm - 7:45 pm
General Discussion
7:45 pm - 7:50 pm
Introduction by Discussion Leader
7:50 pm - 8:10 pm
"Development of an Orally Active Small Molecule Inhibitor of PAI-1 for the Treatment of Systemic Sclerosis"
8:10 pm - 8:20 pm
Discussion
8:20 pm - 8:40 pm
"Stopping Pancreatic Cancer in Its Tracks: Anti-Metastatic and Anti-Immunosuppressive Effects of a Selective uPA Inhibitor in Preclinical Models"
8:40 pm - 8:50 pm
Discussion
8:50 pm - 9:10 pm
"Plasminogen Deficiency and the Potential for Plasminogen Supplementation in Treatment of Pleural Space Infections"
9:10 pm - 9:20 pm
Discussion
9:20 pm - 9:30 pm
Closing Remarks
Friday
7:30 am - 8:30 am
Breakfast
9:00 am
Departure